journal article·2005-11

Synthesis, properties and controlled release behaviors of hydrogel networks using cyclodextrin as pendant groups

Yu-Yang Liu, Xiao-Dong Fan

Biomaterials· Volume 26· Issue 32
Publisher page

Abstract

Based on inclusion character of beta-cyclodextrin (beta-CD) with drug molecule and low glass transition temperature of poly(2-hydroxyethyl acrylate) (PHEA), a series of hydrogels with different compositions were synthesized by the copolymerization of a monovinyl cyclodexrin monomer with 2-hydroxyethyl acrylate (HEA). The structure and properties of the hydrogels were characterized by FTIR, DSC, TGA and swelling measurements. It is found that swelling ratios of these beta-CD hydrogels can keep a relative stability in the range of pH from 1.4 to 7.4, and are not sensitive to change in NaCl concentration. Using drug N-acety-5-methoxytryptamine (melatonin, MEL) as a model molecule, the controlled drug release behaviors of these hydrogels were investigated. The results indicate that the diffusion and permeation of MEL from the hydrogels may be a dominant factor for its release. Owing to the formation of MEL/beta-CD retarding diffusion rate of MEL, a sustained release of MEL from hydrogel with high content of beta-CD can be obtained compared with hydrogel PHEA without beta-CD.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Hydrogels: synthesis, properties, applications · Supramolecular Self-Assembly in Materials · Advanced Drug Delivery Systems

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (36)

Show source-provided references
1. Comb-type grafted hydrogels with rapid de-swelling response to temperature changes10.1038/374240a0 ↗
2. Volume transition in gel driven by hydrogen bonding10.1038/349400a0 ↗
3. Thermal transitions hydrogels of poly(ethyl acrylate)/poly(hydroxyethyl acrylate) interpenetrating networks10.1021/ma970344i ↗
4. Hydrogel for biomedical applications10.1016/S0169-409X(01)00239-3 ↗
5. Pulsatible drug release control using hydrogels10.1016/S0169-409X(01)00243-5 ↗
6. Electrically erodible polymer gel for controlled release of drugs10.1038/354291a0 ↗
7. pH/temperature-responsive behaviors of simi-IPN and comb-type graft hydrogels composed of alginate and poly(N-isopropylacrylamide )10.1016/S0032-3861(01)00143-4 ↗
8. Synthesis and characterization of pH- and temperature-sensitive poly(methacrylic acid)/poly(N-isopropylacylamide) interpenetrating polymeric networks10.1021/ma991398q ↗
9. Synthesis, characterization and controlled drug release of thermosensitive IPN-PNIPAAM hydrogels10.1016/j.biomaterials.2003.10.065 ↗
10. Synthesis and characterization of pH- and temperature-sensitive hydrogel of N-isopropylacrylamide/cyclodextrin based copolymer10.1016/S0032-3861(02)00350-6 ↗
11. Release of chlorambucil from poly(N-Isopropylacrylamide) hydrogels with β-cyclodextrin moieties10.1002/mabi.200400037 ↗
12. A cyclodextrin microgel for controlled release driven by inclusion effects10.1002/marc.200400396 ↗
13. On the restriction of the release of water-soluble component from polyvinyl alcohol film by blending β-Cyclodextrin10.1002/(SICI)1097-4628(19970829)65:9<1829::AID-APP20>3.0.CO;2-G ↗
14. Injectable drug-delivery systems based on supramolecular hydrogels formed by poly(ethylene oxide)s and α-cyclodextrin10.1002/jbm.a.10444 ↗
15. Modulation of drug release from hydrogels by using cyclodextrins: the case of nicardipine/β-cyclodextrin system in crosslinked polyethylenglycol10.1016/S0168-3659(01)00242-5 ↗
16. Pharmaceutical application of cylodextrin.1. Drug solubilization and stabilization10.1021/js950534b ↗
17. Pharmaceutical application of cylodextrin. 2. In vivo drug delivery10.1021/js960075u ↗
18. Pharmaceutical application of cylodextrin. III. Toxicological issues and safety evaluation10.1021/js960213f ↗
19. Cyclodextrin: their future in drug formulation and delivery10.1023/A:1012136608249 ↗
20. Structural and physicochemical characterization of the inclusion complexes of cyclomaltooligosaccharides (cyclodextrins) with melatonin10.1016/S0008-6215(02)00049-6 ↗
21. Cyclodextrin-based controlled drug release system10.1016/S0169-409X(98)00058-1 ↗
22. Mechanism by which cyclodextrins modify drug release from polymeric drug delivery systems10.1016/S0378-5173(00)00335-5 ↗
23. Poly(acrylic acid) microspheres containing β-Cycliodextrin: loading and in vitro release of two dyes10.1016/S0378-5173(99)00190-8 ↗
24. Bioadhesive polymer buccal patches for buprenorphine controlled delivery10.3109/03639049509065885 ↗
25. Preparation and characterization of starch/cyclodextrin bioadhesive microspheres as platform for nasal administration of Gabexate Mesylate (Foy®) in allergic rhinitis treatment10.1016/S0142-9612(03)00477-0 ↗
26. Cross-linked β-cyclodextrin microcapsule: retarding effect on drug release through semi-permeable membranes10.1016/S0378-5173(01)00899-7 ↗
27. Functionalized β-cycliodextrin polymers for the sorption of bile salts10.1081/MA-100101117 ↗
28. Liu YY, Fan XD, Zhao YB. Synthesis and characterization of a poly(N-isopropylacrylamide) with β-cyclodextrin as pendant groups. J Polym Sci Part A: Polym Chem, in press.
29. Synthesis and characterization of β-cyclodextrin based functional monomers and its copolymers with N-isopropylacrylamide10.1002/mabi.200300052 ↗
30. Thermodynamical analysis of the hydrogel state in poly(2-hydroxyethyl acrylate)10.1016/j.polymer.2004.06.039 ↗
31. Porous poly(2-hydroxyethyl acrylate) hydrogels10.1016/S0032-3861(00)00742-4 ↗
32. Melatonin affords protection against kainate-induced in vitro lipid peroxidation in brain10.1016/0014-2999(96)00241-5 ↗
33. Cooperative binding by aggregated mono-6-(alkylamino) β-cyclodextrins10.1021/ja00166a021 ↗
34. He · 1990
35. Synthesis and properties of poly(N-isopropylacrylamide)/β-cyclodextrin ionic polymer
36. Phase transition in linear and cross-linked poly(N-isopropylacylamide) in water: effect of various types of additives10.1081/MC-100100578 ↗